Contents
Adage Capital Management is a Boston based capital management firm founded in 2001 by Phillip Gross and Robert George Atchinson.
The firm has $8.9B under its management and focuses on managing S&P 500 assets mainly for Endowments and Foundations. The firm invests in early-stage and late-stage ventures.
The notable investment portfolio of Adage Capital Management includes, MedAvail, Annexon Biosciences, Cabaletta Bio, GitLab, Precision BioSciences, Prevail Therapeutics, Scout Bio, and Tanium.
As of January 2020, Adage Capital Management has made 41 investments and had 28 exits.
Timeline
Invested in
Open in Query Tool
Patents
Open in Query Tool
Funding Rounds Participated In
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
References
Company attributes
Location
Founded Date
2001
Wellfound ID
Other attributes
Company Operating Status
Active
